Literature DB >> 12761500

Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells.

Wei-Shu Wang1, Po-Min Chen, Hung-Liang Hsiao, Sy-Yeuan Ju, Yeu Su.   

Abstract

Thymosin beta-4 (Tbeta-4), a small peptide originally isolated from calf thymus, modulates the formation of F-actin microfilaments by sequestering the monomeric G-actin. Recent studies have shown that overexpression of the Tbeta-4 gene occurs not only in many human carcinomas but also in the highly metastatic melanomas and fibrosarcomas. However, little is known about the specific growth advantages acquired by different tumors from this genetic abnormality. To address the above questions, Tbeta-4-overexpressing human colon carcinoma (SW480) cells were established by stable transfection and their phenotypic changes were monitored. We found that both the morphology and the cortical actin cytoskeleton of SW480 cells were altered by Tbeta-4 overexpression. Moreover, both cellular level and that distributed over the intercellular junctions of the E-cadherin were decreased in the Tbeta-4 overexpressers, which were accompanied by a twofold increase in their saturation densities. Meanwhile, these cells also exhibited an increased ability to form colonies in soft agar. Interestingly, a dramatic increase of growth rate was detected in the Tbeta-4 overexpressers, which might be attributed to an accelerated proliferation induced by c-Myc that was activated by nuclear beta-catenin. Finally, a motility increase of these cells was demonstrated by two independent migration assays, which was accompanied by an enhanced focal contact. Taken together, our data suggest that the drastic growth property and motility changes of the SW480 cells overexpressing Tbeta-4 gene are due mainly to a deregulated cell-cell adhesion arisen from the downregulation of E-cadherin, plus uncontrolled cell proliferation owing to the upregulation of beta-catenin, both resulted from a breakdown of actin microfilaments caused by the overexpression of this G-actin sequestering peptide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761500     DOI: 10.1038/sj.onc.1206404

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Phylogenetic analysis and developmental expression of thymosin-beta4 gene in amphioxus.

Authors:  Xiangwei Huang; Wei Zhang; Hongwei Zhang
Journal:  Dev Genes Evol       Date:  2005-03-24       Impact factor: 0.900

2.  Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.

Authors:  Syreeta L Tilghman; Ian Townley; Qiu Zhong; Patrick P Carriere; Jin Zou; Shawn D Llopis; Lynez C Preyan; Christopher C Williams; Elena Skripnikova; Melyssa R Bratton; Qiang Zhang; Guangdi Wang
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

3.  Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.

Authors:  Sebastian C J Steiniger; Judith A Coppinger; Jörg A Krüger; John Yates; Kim D Janda
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

4.  In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA.

Authors:  T-C Chao; L-C Chan; S-Y Ju; M-C Tang; C-Y Liu; P-M Chen; C-H Tzeng; Y Su
Journal:  Cancer Gene Ther       Date:  2014-08-15       Impact factor: 5.987

5.  Molecular cloning and structural characterization of the functional human thymosin beta4 gene.

Authors:  Shu-Ping Yang; Hui-Ju Lee; Yeu Su
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

6.  Multiple functional involvement of thymosin beta-4 in tooth germ development.

Authors:  Yukiko F Ookuma; Tamotsu Kiyoshima; Ieyoshi Kobayashi; Kengo Nagata; Hiroko Wada; Hiroaki Fujiwara; Haruyoshi Yamaza; Kazuaki Nonaka; Hidetaka Sakai
Journal:  Histochem Cell Biol       Date:  2012-10-06       Impact factor: 4.304

7.  Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment.

Authors:  Rebecca A Whipple; Agnes M Cheung; Stuart S Martin
Journal:  Exp Cell Res       Date:  2007-02-07       Impact factor: 3.905

8.  Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

Authors:  Jo Caers; Dirk Hose; Ine Kuipers; Tomas Jan Bos; Els Van Valckenborgh; Eline Menu; Elke De Bruyne; Hartmut Goldschmidt; Ben Van Camp; Bernard Klein; Karin Vanderkerken
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

9.  Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation.

Authors:  Yuqing Zhang; Louis W Feurino; Qihui Zhai; Hao Wang; William E Fisher; Changyi Chen; Qizhi Yao; Min Li
Journal:  Cancer Biol Ther       Date:  2007-12-13       Impact factor: 4.742

10.  Gene profiling of cottontail rabbit papillomavirus-induced carcinomas identifies upregulated genes directly Involved in stroma invasion as shown by small interfering RNA-mediated gene silencing.

Authors:  Evamaria Huber; Daniela Vlasny; Sonja Jeckel; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.